Skip to main content

Resveratrol derivative helps obese lab mice live longer – so what?

Do the new findings about the resveratrol derivative SRT-1720 extending the normally shortened lifespan of obese mice tell us anything new? It’s been a long and ultimately disappointing road with the red wine derivative resveratrol, once touted as the basis for miracle anti-aging drugs and now a fading star. As I have described here before, resveratrol was purported to activate an enzyme system known as sirtuins, which in turn activate anti-aging genes that trigger a unique lifespan extension phenomenon normally associated with severe caloric restriction. Take a pill and skip the starvation diet was the promise, and live up to 40% longer. The idea was so compelling that the biotech company Sirtris was founded to exploit more potent (and patentable) resveratrol derivatives such as SRT-1720.


This latest report showed that giving mice resveratrol after rendering them morbidly obese through an unhealthy diet helped them live longer than they normally would have, by improving insulin sensitivity and otherwise normalizing metabolic parameters thrown out of whack by the diet. But there are problems with the study: firstly, the subject mice still didn’t live as long as mice on a healthy diet. Secondly, there isn’t really anything new here; this has all been reported before.

The real problem is that neither resveratrol nor any of its derivatives has been proven to directly activate sirtuins in the first place. In fact, several labs other than Sirtris have definitely concluded that it doesn’t, that the initial reports were an artifact of the testing method. SRT-1720 may prove to be a useful drug for type 2 diabetes, joining a crowded market. But – and here’s the interesting twist – another diabetes drug, metformin, does extend lifespan in mice on a normal diet.

I have always been a little bit uncomfortable with attributing wine’s well-established health benefits to resveratrol. There isn’t enough resveratrol in wine to explain all of the good things that a glass or two with dinner imparts. There are a lot of things in wine besides resveratrol, including alcohol, and a lot of healthy habits that moderate wine drinkers have. So while I wish the good people at Sirtris all the best of luck, let’s not forget the simple things we can do for a long and healthy life now.

Comments

Popular posts from this blog

Wear red and DRINK red for women’s heart health

This Friday Feb 2nd is the annual “wear red” day in Canada and the U.S. to raise awareness for women’s heart health. Why only a day for the number one threat to women’s health? Women are 5 times more likely to succumb to heart disease than breast cancer, which gets a whole month (October.) Another contradiction is that the advice women hear about prevention of breast cancer is the opposite of what you can do to lower the risk of heart disease: a daily glass of wine. Even one drink a day raises your risk of breast cancer, we are told, ignoring the overriding benefits of wine on heart health. Drink red wine to live longer Here’s why I think women should also “drink red.” For starters, wine helps de-stress and celebrates life. Stress is a factor in heart disease, and if that were the only way wine helped it would be worth considering. But the medical evidence is also strong: a daily glass of red wine helps raise the HDL “good cholesterol” levels, which lowers the risk of cardiovascular p…

Which types of wine are the healthiest?

I am often asked after lecturing on the healthful properties of wine which type is best to drink. Since much of the discussion has to do with the polyphenol antioxidants from the skins and seeds of the grape, red wine is the first criterion since it is fermented with the whole grape rather than the pressed juice. This allows for extraction and concentration of these compounds, familiar ones being resveratrol and tannins. But beyond that, which varietals have the highest concentrations?


According to the Roman philosopher Pliny the Elder, “The best kind of wine is that which is pleasant to him that drinks it” but modern science expects more specifics. (The point of course is that if you have a wine that you enjoy you are more likely to drink regularly and therefore reap the benefits.) But there are several difficulties in singling out certain wines for their healthful properties. Which compounds to measure? Are we talking about heart health or the whole gamut? Is it the varietal of the …

The J-curve is dead. Long live the J-curve!

There is a resurgence of debate about the validity of the J-curve, especially as it relates to alcohol and cancer. A 2014 report determined that “alcohol use was positively associated with overall mortality, alcohol-related cancers, and violent death and injuries, but marginally to CVD/CHD” (cardiovascular disease). In other words, there was little benefit if any in terms of heart disease but a big upside risk for cancer and accidental or violent demise. Gone was the French Paradox! The J curve is dead! Or not. Though that statement may be technically true, I looked at look at the data myself and found something different: a strong confirmation of the J-curve for overall mortality, overall cancer deaths, cardiovascular disease, and all “other causes.” This held for both men and women:
    Used under creative commons license from Ferrari P, Licaj I,Muller DC, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nu…